CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,798,272 | 1,798,272 | ||
| 2023-01-12 | Bertrand William C JR Chief Operating Officer | Sale | −4,973 | $1.71 | $8K | 8,121 |
| 2023-01-12 | Lunger John Chief Patient Supply Officer | Sale | −4,973 | $1.71 | $8K | 8,121 |
| 2023-01-12 | Norry Elliot Chief Medical Officer | Sale | −7,449 | $1.71 | $13K | 12,191 |
| 2023-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −18,763 | $1.71 | $32K | 24,882 |
| 2023-01-11 | Bertrand William C JR Chief Operating Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
| 2023-01-11 | Lunger John Chief Patient Supply Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
| 2023-01-11 | Norry Elliot Chief Medical Officer | Sale | −3,843 | $1.75 | $7K | 6,270 |
| 2023-01-11 | Rawcliffe Adrian Chief Executive Officer | Sale | −13,042 | $1.75 | $23K | 17,298 |
| 2023-01-04 | Bertrand William C JR Chief Operating Officer | Sale | −3,584 | $1.69 | $6K | 5,781 |
| 2023-01-04 | Lunger John Chief Patient Supply Officer | Sale | −1,100 | $1.69 | $2K | 1,725 |
| 2023-01-04 | Norry Elliot Chief Medical Officer | Sale | −876 | $1.69 | $1K | 1,361 |
| 2023-01-04 | Rawcliffe Adrian Chief Executive Officer | Sale | −5,073 | $1.69 | $9K | 6,631 |
| 2022-09-01 | Rawcliffe Adrian Chief Executive Officer | Sale | −2,536 | $1.97 | $5K | 3,316 |
| 2022-08-01 | Lunger John Chief Patient Supply Officer | Sale | −2,983 | $1.77 | $5K | 4,829 |
| 2022-08-01 | Piccina Cintia Chief Commercial Officer | Sale | −21,040 | $1.77 | $37K | 34,824 |
| 2022-07-05 | Lunger John Chief Patient Supply Officer | Sale | −1,973 | $1.68 | $3K | 3,104 |
| 2022-07-01 | Behbahani Ali Director | Grant or award · Option to purchase Ordinary Shares | +737,050 | 737,050 | ||
| 2022-07-01 | Zaks Tal Zvi Director | Grant or award · Option to purchase Ordinary Shares | +500,000 | 500,000 | ||
| 2022-07-01 | Alleva Lawrence M Director | Grant or award · Option to purchase Ordinary Shares | +816,067 | 816,067 |
Page 8 of 23 · 454 trades